0,964  0,004  Antiinflammatory
0,952  0,003  Antileukemic
0,952  0,004  Apoptosis agonist
0,937  0,004  Antineoplastic (lung cancer)
0,934  0,004  Antineoplastic (breast cancer)
0,919  0,003  Nitric oxide antagonist
0,919  0,004  Antineoplastic (melanoma)
0,908  0,002  Sensitization
0,903  0,004  Antineoplastic (colorectal cancer)
0,901  0,004  Antineoplastic (colon cancer)
0,870  0,004  Antineoplastic (ovarian cancer)
0,862  0,003  Antineoplastic (pancreatic cancer)
0,865  0,009  Transcription factor NF kappa B inhibitor
0,859  0,003  Antineoplastic (liver cancer)
0,858  0,004  Antineoplastic (glioma)
0,842  0,003  Antineoplastic (glioblastoma multiforme)
0,822  0,002  Antialcoholic
0,814  0,004  Antineoplastic (carcinoma)
0,795  0,004  Tumour necrosis factor alpha release inhibitor
0,787  0,004  Apoptosis antagonist
0,778  0,005  Prostate cancer treatment
0,759  0,004  Antineoplastic (multiple myeloma)
0,757  0,005  Antineoplastic (non-small cell lung cancer)
0,711  0,004  Antineoplastic (squamous cell carcinoma)
0,704  0,003  Sepsis treatment
0,689  0,004  Antineoplastic (sarcoma)
0,681  0,004  Antineoplastic (renal cancer)
0,683  0,008  Bone diseases treatment
0,680  0,010  Antiprotozoal
0,618  0,005  Antineoplastic (lymphoma)
0,618  0,012  Antineoplastic (cervical cancer)
0,611  0,012  Immunosuppressant
0,588  0,004  ICAM1 expression inhibitor
0,587  0,005  Antiulcerative
0,580  0,008  Antiprotozoal (Trypanosoma)
0,582  0,013  Cardiovascular analeptic
0,581  0,013  Hepatic disorders treatment
0,554  0,004  Platelet adhesion inhibitor
0,559  0,013  Antineoplastic (brain cancer)
0,545  0,003  T cell inhibitor
0,555  0,015  Cytostatic
0,548  0,016  Cardioprotectant
0,528  0,008  Antineoplastic (lymphocytic leukemia)
0,517  0,006  Hepatoprotectant
0,537  0,031  Antibacterial
0,506  0,005  Diabetic nephropathy treatment
0,513  0,019  Antiosteoporotic
0,485  0,008  Septic shock treatment
0,494  0,025  Cytotoxic
0,472  0,006  Shock treatment
0,474  0,013  Antineoplastic enhancer
0,481  0,021  NOS2 expression inhibitor
0,470  0,020  Antiprotozoal (Leishmania)
0,481  0,045  GST A substrate
0,439  0,006  Liver fibrosis treatment
0,469  0,040  Antineoplastic (myeloid leukemia)
0,454  0,026  Antioxidant
0,415  0,004  Aromatase inhibitor
0,403  0,004  UDP-N-acetylglucosamine 1-carboxyvinyltransferase inhibitor
0,422  0,039  Antifungal
0,401  0,019  Transcription factor STAT inhibitor
0,434  0,054  Antipruritic, allergic
0,380  0,011  Pneumotoxic
0,405  0,037  Analeptic
0,379  0,011  VCAM1 expression inhibitor
0,375  0,017  Contraceptive
0,365  0,019  GST M1-1 substrate
0,394  0,051  Antithrombotic
0,423  0,098  Caspase 9 stimulant
0,332  0,013  Antiviral (Influenza A)
0,351  0,034  Chemopreventive
0,319  0,003  Hypercalcemia treatment
0,358  0,054  Respiratory analeptic
0,339  0,038  Mutagenic
0,333  0,034  DNA synthesis inhibitor
0,316  0,018  Interferon gamma antagonist
0,348  0,051  Calcium channel activator
0,323  0,030  Abortion inducer
0,315  0,028  Antihelmintic
0,324  0,037  Antiparasitic
0,371  0,089  TNF expression inhibitor
0,300  0,019  Prostate disorders treatment
0,293  0,023  Antiacne
0,306  0,044  Carcinogenic
0,308  0,050  Transcription factor STAT3 inhibitor
0,311  0,053  DNA damaging
0,300  0,045  5 Hydroxytryptamine uptake stimulant
0,268  0,014  Antifungal enhancer
0,313  0,060  Antineoplastic (endocrine cancer)
0,271  0,021  Bone formation stimulant
0,270  0,028  Antipruritic, non-allergic
0,259  0,018  Antidiarrheal
0,241  0,013  Farnesoid X receptor antagonist
0,319  0,091  CYP3A4 substrate
0,232  0,013  Microtubule formation inhibitor
0,259  0,043  Antiviral (Influenza)
0,293  0,087  AR expression inhibitor
0,279  0,074  Antihypoxic
0,246  0,043  UGT2B7 substrate
0,233  0,031  Protein kinase stimulant
0,303  0,104  CYP2C9 substrate
0,255  0,074  Antipyretic
0,201  0,021  Antineoplastic antibiotic
0,230  0,053  Sigma receptor agonist
0,259  0,083  UGT2B4 substrate
0,261  0,086  Radioprotector
0,280  0,105  Vasodilator, coronary
0,250  0,076  Proliferative diseases treatment
0,183  0,010  Inducible nitric-oxide synthase inhibitor
0,183  0,018  Antineoplastic alkaloid
0,238  0,074  Free radical scavenger
0,278  0,114  Antiprotozoal (Plasmodium)
0,195  0,032  Cyclooxygenase 2 inhibitor
0,253  0,090  CYP2C19 substrate
0,171  0,009  Paget's disease treatment
0,171  0,012  Ca2+-transporting ATPase inhibitor
0,246  0,093  Spasmolytic
0,213  0,061  Non-steroidal antiinflammatory agent
0,284  0,133  Histamine release inhibitor
0,162  0,012  Anabolic
0,192  0,043  UGT2B9 substrate
0,201  0,053  Tumour necrosis factor antagonist
0,191  0,048  Hair growth stimulant
0,195  0,056  Antineoplastic (gastric cancer)
0,185  0,048  Arachidonic acid antagonist
0,163  0,026  Mucolytic
0,163  0,027  Gastritis treatment
0,181  0,045  Genotoxic
0,159  0,028  Contraceptive female
0,162  0,031  Expectorant
0,136  0,009  Na+ K+ transporting ATPase inhibitor
0,178  0,052  Cyclooxygenase inhibitor
0,179  0,052  Melanin inhibitor
0,218  0,095  Aldehyde oxidase inhibitor
0,179  0,057  UGT2B10 substrate
0,168  0,047  Carcinogenic, group 3
0,128  0,010  Glycine receptor agonist
0,120  0,003  Vitamin D receptor antagonist
0,125  0,015  Glycine receptor antagonist
0,110  0,007  Glutamate (mGluR6) antagonist
0,185  0,083  UGT1A1 substrate
0,225  0,124  NOS3 expression inhibitor
0,175  0,076  Antirickettsial
0,246  0,148  Antineoplastic (small cell lung cancer)
0,211  0,114  Immunostimulant
0,187  0,090  Neurotrophic factor enhancer
0,232  0,136  Angiogenesis inhibitor
0,121  0,027  Antibiotic
0,126  0,033  GST T1-1 substrate
0,213  0,120  Chemoprotective
0,173  0,081  LDLR expression enhancer
0,266  0,175  Transcription factor inhibitor
0,158  0,070  Carcinogenic, group 1
0,145  0,058  Alpha-N-acetylglucosaminidase inhibitor
0,155  0,069  Acaricide
0,129  0,044  GABA C receptor antagonist
0,089  0,004  Parathyroid hormone antagonist
0,149  0,064  Adenylate cyclase stimulant
0,193  0,110  RNA-directed DNA polymerase inhibitor
0,090  0,009  Postcoital contraceptive
0,205  0,123  Flavin-containing monooxygenase substrate
0,184  0,103  Angiogenesis stimulant
0,130  0,049  Carcinogenic, group 2B
0,231  0,151  FMO1 substrate
0,091  0,013  Estrogen receptor beta agonist
0,199  0,122  Interleukin agonist
0,112  0,037  Thioredoxin inhibitor
0,134  0,059  Vanilloid 1 agonist
0,102  0,029  Nicotinic alpha4beta2 receptor antagonist
0,166  0,094  Antieczematic atopic
0,083  0,011  Estrogen receptor alpha agonist
0,162  0,092  Succinate dehydrogenase inhibitor
0,149  0,079  Diuretic
0,144  0,074  UGT2B15 substrate
0,166  0,097  UDP-glucuronosyltransferase substrate
0,107  0,038  Antispirochetal
0,095  0,028  Narcotic antagonist
0,110  0,046  Nitric-oxide synthase inhibitor
0,097  0,033  Phosphofructokinase-1 inhibitor
0,109  0,046  UGT2B11 substrate
0,104  0,042  Bile acid receptor antagonist
0,155  0,094  ATPase inhibitor
0,071  0,014  Anesthetic inhalation
0,065  0,010  Microtubule stabilization
0,184  0,130  Antihypotensive
0,087  0,036  CDC25A inhibitor
0,075  0,025  Estrogen agonist
0,143  0,093  Prostatic (benign) hyperplasia treatment
0,064  0,015  5-Alpha-reductase inhibitor
0,208  0,158  Caspase 3 stimulant
0,114  0,065  Monophenol monooxygenase inhibitor
0,144  0,094  Uterine stimulant
0,138  0,090  Eye irritation, high
0,162  0,115  Teratogen
0,206  0,159  Cholesterol antagonist
0,118  0,072  Antiprotozoal (Amoeba)
0,153  0,110  Antiviral (Hepatitis)
0,120  0,078  Acetylcholinesterase inhibitor
0,049  0,009  Tubulin agonist
0,147  0,107  Sedative
0,136  0,097  UGT1A4 substrate
0,074  0,036  SULT2A1 substrate
0,049  0,012  Glutamate (mGluR8) agonist
0,036  0,004  Progesterone receptor B antagonist
0,102  0,071  Choleretic
0,090  0,059  Actinic keratosis treatment
0,098  0,068  GABA C receptor agonist
0,064  0,036  Androgen agonist
0,101  0,073  Excitatory amino acid transporter EAAC1 inhibitor
0,086  0,057  Carcinogenic, group 2A
0,036  0,008  CYP24 inhibitor
0,086  0,058  Transcription factor NF kappa B stimulant
0,107  0,079  Cholesterol synthesis inhibitor
0,169  0,143  Antidiabetic symptomatic
0,108  0,084  Antiseptic
0,049  0,025  Opioid kappa receptor agonist
0,146  0,122  Embryotoxic
0,108  0,085  Transcription factor STAT6 inhibitor
0,068  0,045  Vanilloid 1 antagonist
0,147  0,125  Phobic disorders treatment
0,086  0,065  Antidote, mercury
0,198  0,177  CTGF expression inhibitor
0,055  0,035  Protein 50S ribosomal subunit inhibitor
0,106  0,088  Growth stimulant
0,049  0,031  Glucose-6-phosphate isomerase inhibitor
0,035  0,016  Glutamate (mGluR3) agonist
0,074  0,058  Keratolytic
0,106  0,091  Amylase inhibitor
0,054  0,038  Acyl-CoA dehydrogenase inhibitor
0,075  0,060  Acetylcholine nicotinic antagonist
0,023  0,009  Progesterone agonist
0,168  0,155  5 Hydroxytryptamine release stimulant
0,062  0,052  Neuronal nicotinic receptor antagonist
0,050  0,039  Aconitate hydratase inhibitor
0,040  0,030  Kainate receptor agonist
0,059  0,049  Antimycoplasmal
0,079  0,069  Ornithine decarboxylase inhibitor
0,102  0,094  Aldehyde dehydrogenase inhibitor
0,191  0,183  FMO3 substrate
0,059  0,051  Hyperparathyroidism treatment
0,055  0,049  Lipocortins synthesis agonist
0,135  0,130  Lipocortins synthesis antagonist
0,049  0,045  Nicotinic alpha3beta2 receptor antagonist
0,024  0,020  Vanilloid 2 agonist
0,049  0,046  Postmenopausal disorders treatment
0,005  0,002  Vitamin D-like
0,106  0,104  Antifungal (Pneumocystis)
0,041  0,041  Potassium channel Kv1.3 blocker
0,063  0,062  Exportin-1 inhibitor

